Dr. Marwa Badawy, MD

NPI: 1306373774
Total Payments
$706.04
2024 Payments
$114.99
Companies
10
Transactions
17
Medicare Patients
83
Medicare Billing
$9,983

Payment Breakdown by Category

Food & Beverage$706.04 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $706.04 17 100.0%

Top Paying Companies

Company Total Records Latest Year
Alkermes, Inc. $303.60 6 $0 (2020)
VERTEX PHARMACEUTICALS INCORPORATED $114.99 1 $0 (2024)
Janssen Pharmaceuticals, Inc $80.98 1 $0 (2019)
Sunovion Pharmaceuticals Inc. $80.98 1 $0 (2019)
Otsuka America Pharmaceutical, Inc. $49.05 3 $0 (2019)
Indivior Inc. $18.75 1 $0 (2019)
Shire North American Group Inc $17.06 1 $0 (2019)
Neurocrine Biosciences, Inc. $14.15 1 $0 (2019)
Lundbeck LLC $13.67 1 $0 (2019)
Takeda Pharmaceuticals U.S.A., Inc. $12.81 1 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $114.99 1 VERTEX PHARMACEUTICALS INCORPORATED ($114.99)
2020 $119.37 3 Alkermes, Inc. ($106.56)
2019 $471.68 13 Alkermes, Inc. ($197.04)

All Payment Transactions

17 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/18/2024 VERTEX PHARMACEUTICALS INCORPORATED Food and Beverage In-kind items and services $114.99 General
08/11/2020 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $89.84 General
Category: CNS
02/27/2020 Alkermes, Inc. Vivitrol (Drug) Food and Beverage In-kind items and services $16.72 General
Category: CNS
02/25/2020 Takeda Pharmaceuticals U.S.A., Inc. VYVANSE (Drug) Food and Beverage In-kind items and services $12.81 General
Category: NEUROSCIENCE
11/18/2019 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $17.06 General
Category: NEUROSCIENCE
11/07/2019 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $18.97 General
Category: CNS
10/24/2019 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $14.15 General
Category: NEUROLOGY
10/17/2019 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $21.64 General
Category: PSYCHIATRY
10/09/2019 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $85.87 General
Category: CNS
09/12/2019 Indivior Inc. PERSERIS (Drug) Food and Beverage In-kind items and services $18.75 General
Category: BH
09/09/2019 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $15.75 General
Category: PSYCHIATRY
08/19/2019 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $11.66 General
Category: PSYCHIATRY
08/15/2019 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $80.98 General
Category: Neuroscience
08/15/2019 Lundbeck LLC BRINTELLIX (Drug) Food and Beverage Cash or cash equivalent $13.67 General
Category: PSYCHIATRY
08/12/2019 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $11.05 General
Category: CNS
06/18/2019 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $81.15 General
Category: CNS
06/03/2019 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $80.98 General
Category: CNS

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 32 73 $11,964 $4,179
2022 3 51 78 $12,941 $5,804
Total Patients
83
Total Services
151
Medicare Billing
$9,983
Procedure Codes
4

All Medicare Procedures & Services

4 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 32 73 $11,964 $4,179 34.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 22 42 $6,710 $2,908 43.3%
90792 Psychiatric diagnostic evaluation with medical services Office 2022 17 17 $3,964 $2,073 52.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 12 19 $2,267 $823.20 36.3%

About Dr. Marwa Badawy, MD

Dr. Marwa Badawy, MD is a Psychiatry healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2017. The National Provider Identifier (NPI) number assigned to this provider is 1306373774.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marwa Badawy, MD has received a total of $706.04 in payments from pharmaceutical and medical device companies, with $114.99 received in 2024. These payments were reported across 17 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($706.04).

As a Medicare-enrolled provider, Badawy has provided services to 83 Medicare beneficiaries, totaling 151 services with total Medicare billing of $9,983. Data is available for 2 years (2022–2023), covering 4 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location Springfield, MO
  • Active Since 05/17/2017
  • Last Updated 03/14/2025
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1306373774

Products in Payments

  • ARISTADA (Drug) $286.88
  • INVEGA SUSTENNA (Drug) $80.98
  • LATUDA (Drug) $80.98
  • ABILIFY MAINTENA (Drug) $49.05
  • VYVANSE (Drug) $29.87
  • PERSERIS (Drug) $18.75
  • Vivitrol (Drug) $16.72
  • INGREZZA (Drug) $14.15
  • BRINTELLIX (Drug) $13.67

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Springfield